Basel Medical Group (BMGL) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Basel Medical Group (BMGL) is Moderate Underperform.

The composite score behind that read is -0.39, weighing +0.00 of bullish evidence against -0.40 bearish.

Basel Medical Group last closed at $3.33, +5.05% on the session.

Against the IVW growth benchmark the position is +4.44% over the forecast window.

The read is built from 11 underlying insights — 0 bullish and 11 bearish.

Agreement across those insights is 100%.

17 graded predictions for BMGL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Basel Medical Group is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $4.96M.

StockMap tracks Basel Medical Group as the 80th largest of the 80 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Neutral and 26 Moderate Underperform.

On that composite Basel Medical Group ranks 78th of 80 in the group, against a group median of -0.13.